Cargando…

Inflammation characteristics and anti-inflammation treatment with tocilizumab of severe/critical COVID-19 patients: A retrospective cohort study

The efficacy of tocilizumab on the prognosis of severe/critical COVID-19 patients is still controversial so far. We aimed to delineate the inflammation characteristics of severe/critical COVID-19 patients and determine the impact of tocilizumab on hospital mortality. Here, we performed a retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Qin, Xu, Yu, Xiang, Ying, Wang, Bin, Yuan, Zhiquan, Shan, Yifan, Zhang, Wenjing, Wu, Na, Xia, Tingting, Li, Chengying, Xie, Weijia, Jia, Xiaoyue, Yu, Zubin, Bai, Li, Li, Yafei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193270/ https://www.ncbi.nlm.nih.gov/pubmed/34131411 http://dx.doi.org/10.7150/ijbs.56952

Ejemplares similares

Early kidney injury predicts disease progression in patients with COVID-19: a cohort study
por: Xia, Tingting, et al.
Publicado: (2021)

Risk stratification scores for hospitalization duration and disease progression in moderate and severe patients with COVID-19
por: Huang, Jiaqi, et al.
Publicado: (2021)

Fasting plasma glucose and glucose fluctuation are associated with COVID-19 prognosis regardless of pre-existing diabetes
por: Xie, Weijia, et al.
Publicado: (2021)

Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
por: Liu, Qingyun, et al.
Publicado: (2016)

Circular RNA mmu_circ_0005019 inhibits fibrosis of cardiac fibroblasts and reverses electrical remodeling of cardiomyocytes
por: Wu, Na, et al.
Publicado: (2021)

Single‐nucleotide polymorphism rs4142441 and MYC co‐modulated long non‐coding RNA OSER1‐AS1 suppresses non‐small cell lung cancer by sequestering ELAVL1
por: Xie, Weijia, et al.
Publicado: (2021)

Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer
por: Xu, Yu, et al.
Publicado: (2023)

Circulating Long Noncoding RNAs Act as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
por: Yuan, Shuai, et al.
Publicado: (2020)

Prognostic value of interleukin-34 and interleukin-38 in patients with newly diagnosed atrial fibrillation
por: Ma, Jiaxue, et al.
Publicado: (2023)

Long non-coding RNA MUC5B-AS1 promotes metastasis through mutually regulating MUC5B expression in lung adenocarcinoma
por: Yuan, Shuai, et al.
Publicado: (2018)

Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19
por: Szabo, Robert, et al.
Publicado: (2023)

Prediction Model of New Onset Atrial Fibrillation in Patients with Acute Coronary Syndrome
por: Wu, Na, et al.
Publicado: (2023)

Role of circulating long non-coding RNA for the improvement of the predictive ability of the CHA(2)DS(2)–VASc score in patients with atrial fibrillation
por: Zhang, Yuanbo, et al.
Publicado: (2022)

Hypoxia‐sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR‐30a‐3p in non‐small cell lung cancer
por: Yuan, Shuai, et al.
Publicado: (2019)

Tocilizumab for severe COVID-19: A promising intervention affecting inflammation and coagulation
por: Levi, Marcel
Publicado: (2020)

Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients
por: de Roquetaillade, Charles, et al.
Publicado: (2022)

Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Fatigue Is Not Associated With Objective Assessments of Inflammation During Tocilizumab Treatment of Patients With Rheumatoid Arthritis
por: Hammer, Hilde Berner, et al.
Publicado: (2021)

Tocilizumab in a Case of Refractory Idiopathic Orbital Inflammation: 6-Year Follow-Up Outcomes
por: Artaechevarria Artieda, June, et al.
Publicado: (2020)

Pharmacodynamics of Dracorhodin Perchlorate and Its Inflammation-Targeting Emulsion Gel for Wound Healing
por: Wang, Xiaojie, et al.
Publicado: (2022)

Delayed inflammation decrease is associated with mortality in Tocilizumab-treated critically ill SARS-CoV-2 patients: A retrospective matched-cohort analysis
por: Urbina, Tomas, et al.
Publicado: (2022)

Successful treatment of a critical COVID-19 patient with tocilizumab
por: Tsao, Shih-Ming, et al.
Publicado: (2021)

Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation
por: Zarinsefat, Arya, et al.
Publicado: (2021)

Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients
por: Zeng, Jia, et al.
Publicado: (2020)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

Inflammation to cancer: The molecular biology in the pancreas (Review)
por: LING, SUNBIN, et al.
Publicado: (2014)

Depletion of microglia exacerbates postischemic inflammation and brain injury
por: Jin, Wei-Na, et al.
Publicado: (2017)

563. Tocilizumab in the Treatment of Critical COVID-19 Pneumonia
por: Fisher, Matthew, et al.
Publicado: (2020)

NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics
por: Lu, Na, et al.
Publicado: (2022)

Magnesium enhances the chondrogenic differentiation of mesenchymal stem cells by inhibiting activated macrophage-induced inflammation
por: Hu, Tu, et al.
Publicado: (2018)

Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?
por: Li, Letao, et al.
Publicado: (2022)

Schizophrenia and Inflammation Research: A Bibliometric Analysis
por: Sun, He-Li, et al.
Publicado: (2022)

Inflammation and Infection in Critical Care Medicine
por: Bermejo-Martin, Jesús F., et al.
Publicado: (2014)

A critical role for plasminogen in inflammation
por: Baker, Sarah K., et al.
Publicado: (2020)

Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation
por: He, Yu-Mei, et al.
Publicado: (2018)

Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis
por: Hushaw, Linda L, et al.
Publicado: (2010)

Tocilizumab in critically ill COVID-19 patients: An observational study
por: Mushtaq, Muhammad Z., et al.
Publicado: (2022)

Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation
por: Khandaker, Golam M, et al.
Publicado: (2018)

Progranulin Regulates Inflammation and Tumor
por: Liu, Chunxiao, et al.
Publicado: (2020)

Smad3 Signatures in Renal Inflammation and Fibrosis
por: Wu, Wenjing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fm2o5j85c7omdm24qr8hg22e96